A23V 2250/5058
Glucomannan
A23V2250/5058 (Glucomannan) appears on 5 US grants and 10 published applications in this corpus.
Search patents in A23V- Granted patents
- 5
- Published applications
- 10
- Assignees
- 5
- Inventors
- 18
- Latest grant
- 19 Oct 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 1 | 0 |
| 2013 | 1 | 1 |
| 2014 | 1 | 2 |
| 2015 | 1 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 2 |
| 2020 | 0 | 0 |
| 2021 | 1 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Methods and compositions for reducing oil separation in nut butters19 Oct 2021US 11,147,284 B2Nut Butter Concepts, LLC
- Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4)-glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function3 Nov 2015US 9,173,926 B2OmniGen Research, LLC
- Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4)-glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function16 Sep 2014US 8,834,868 B2OmniGen Research, LLC
- Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4)-glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function29 Oct 2013US 8,568,715 B2OmniGen Research, LLC
- Use of β-1,3 (4)-endoglucanohydrolase, β-1,3 (4) glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function7 Aug 2012US 8,236,303 B2OmniGen Research, LLC
- Method of making a seafood analogue11 Sep 2025US 2025/0280859 A1Societe des Produits Nestle S. A.
- Meat alternative product and process11 Jul 2024US 2024/0225028 A1
- Methods and compositions for reducing oil separation in nut butters24 Oct 2019US 2019/0320675 A1Nut Butter Concepts, LLC
- Savoury concentrate comprising structured aqueous phase2 May 2019US 2019/0124965 A1Conopco, Inc., d/b/a UNILEVER
- Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4)-glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function12 May 2016US 2016/0129092 A1OmniGen Research, LLC
Most cited
By later US patents
- Use of β-1,3 (4)-endoglucanohydrolase, β-1,3 (4) glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function6US 8,236,303 B2OmniGen Research, LLC · 2012
- Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4)-glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function5US 8,568,715 B2OmniGen Research, LLC · 2013
- Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4)-glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function5US 8,834,868 B2OmniGen Research, LLC · 2014
- Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4)-glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function3US 9,173,926 B2OmniGen Research, LLC · 2015